• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 07P89-74
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/05/2024
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, list number 07p89-74 and there is a similar product distributed in the us, list number 7p88.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported false elevated alinity i anti-hbs and provided the following data: the anti-hbs result was 52.82 miu/ml and repeat was 49.84 miu/ml (reference: based on the world health organization recommendation, an antihbs concentration = 10 miu/ml is regarded as being protective) the customer tested the sample on the maccura platform, and the result was negative (no value provided); the colloidal gold result was negative.Additional laboratory information: hbsag/hbeag/anti-hbc were positive.The customer confirmed that they are not questioning any of the additional laboratory results.Patient information: 58 year-old man, clinically diagnosed with a remote rib fracture.Per the customer the discrepant results were not reported out to the patient¿s medical provider.There was no reported impact to patient management.There was no reported impact to patient management.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, trending review, labeling review, device history record review, and field data review.Return testing was not completed as returns were not yet available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Device history review for the complaint lot did not identify any non-conformances or deviations associated with the customer reported issue.Ticket search by lot did not identify an increase in complaint activity for the complaint lot.Trending review has not identified any trends.The overall performance of alinity i anti-hbs was reviewed using field data from customers.The review found that the patient median result is comparable with all other lots in the field and within established baselines, confirming no systemic issue.Labeling was reviewed and was found to address the customer reported issue.Based on the available information, no systemic issue or deficiency was identified for the alinity i anti-hbs reagent lot 51253fn01.
 
Event Description
The customer reported false elevated alinity i anti-hbs and provided the following data: the anti-hbs result was 52.82 miu/ml and repeat was 49.84 miu/ml (reference: based on the world health organization recommendation, an antihbs concentration = 10 miu/ml is regarded as being protective) the customer tested the sample on the maccura platform, and the result was negative (no value provided); the colloidal gold result was negative.Additional laboratory information: hbsag/hbeag/anti-hbc were positive.The customer confirmed that they are not questioning any of the additional laboratory results.Patient information: 58 year-old man, clinically diagnosed with a remote rib fracture.Per the customer the discrepant results were not reported out to the patient¿s medical provider.There was no reported impact to patient management.There was no reported impact to patient management.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I ANTI-HBS REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18898492
MDR Text Key337621731
Report Number3008344661-2024-00035
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07P89-74
Device Lot Number51253FN01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/05/2024
Initial Date FDA Received03/13/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/30/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/19/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6); ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
Patient Age58 YR
Patient SexMale
-
-